SAN MATEO, CA, Route 92 Medical, a privately held medical technology company, announced it has raised over $31 million in a Series F financing led by U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group.
Route 92 Medical, a privately held medical technology company, announced it has raised over $31 million in a Series F financing to accelerate the commercial adoption of a neurovascular intervention portfolio focused on acute ischemic stroke. The capital raise was led by existing venture capital investors: U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and The Vertical Group.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
